SB 955, now known as the "Medical Ethics Defense Act," protects Tennessee healthcare providers from being forced to participate in or pay for medical procedures that conflict with their conscience. It defines "conscience" as sincerely held ethical, moral, or religious beliefs and prohibits discriminatory actions - like termination or penalties - against providers who refuse specific procedures based on those beliefs. The law also safeguards providers who report violations of this act, preventing retaliation for whistleblowing. This applies to healthcare professionals, institutions, and payers but excludes procedures governed by federal law (such as emergency care under EMTALA).
SB 449, the "Fertility Treatment and Contraceptive Protection Act," establishes legal rights for individuals in Tennessee to access fertility treatments and contraception without state prohibition. It defines "fertility treatment" broadly to include procedures like in vitro fertilization, genetic testing of embryos, and medication for fertility, while defining "contraception" to cover methods such as birth control pills, emergency contraceptives, and sterilization. The law explicitly states that Tennessee law does not prohibit these activities, overriding conflicting state laws. This act takes effect on July 1, 2025, directly affecting all residents seeking these health services within the state.
HB 1198 requires Tennessee health insurers and TennCare to allow patients to try biosimilar drugs (cost-effective copies of brand-name medications) before covering the original branded drug. It amends state law to permit health carriers to mandate a biosimilar trial for equivalent branded prescriptions, removing prior requirements for generic drug trials. The bill also directs TennCare’s pharmacy committee to consider biosimilar drugs when recommending medications for the state’s preferred drug list. These changes aim to reduce prescription drug costs by increasing biosimilar adoption, as stated in the bill’s legislative findings.
SB 789 amends Tennessee's licensure rules for marriage and family therapists to clarify student and trainee roles, update supervisor qualifications, and revise associate license requirements. It allows students in accredited programs to use titles like "marital therapy intern" under supervision, expands the definition of "approved supervisor" to include more licensed mental health professionals, and requires associate license holders to pass a licensing exam within nine months while practicing under supervision. The bill also specifies that associate license holders must display their status as "associate licensed marriage and family therapist" (AMFT) and cannot claim full licensure. These changes directly affect therapy students, trainees, and practitioners seeking licensure in Tennessee.
SB 428 requires insurers offering health insurance plans to Tennessee state employees to treat non-opioid pain medications (FDA-approved for pain treatment) equally with opioids on their preferred drug list, ensuring they are not disadvantaged in coverage or discouraged. It also mandates separate reimbursement for healthcare providers and hospitals when non-opioid pain treatments are provided to covered employees. The law applies immediately upon FDA approval of a non-opioid drug and takes effect July 1, 2025. This directly affects insurers and state employee health plans under Tennessee Code.
HB 959 updates Tennessee's licensure rules for marriage and family therapists. It allows students in accredited programs to use titles like "marital therapy intern" while supervised, and clarifies that associate license holders must use "associate licensed marriage and family therapist" or "AMFT" (not implying full licensure). The bill creates specific pathways for associate licensure, requiring a 9-month exam deadline and supervised practice under approved supervisors, while defining "approved supervisor" to include AAMFT-approved professionals. These changes directly affect therapy students, trainees, and practitioners seeking licensure in Tennessee.
HB 843 declares Perry County Community Hospital in Linden and Decatur County General Hospital in Parsons as "necessary providers" of healthcare services for federal critical access hospital (CAH) designation eligibility under Section 1820 of the Social Security Act. This enables both hospitals to qualify for federal CAH status, which provides crucial financial support and resources to sustain operations in rural areas. The bill directly affects these two specific hospitals, ensuring they can access federal benefits to continue serving vulnerable rural communities in Perry and Decatur counties. It requires the Tennessee Department of Health and Health Facilities Commission to facilitate the federal designation process.
SB 138 requires the TennCare program to reimburse air ambulance services operating within Tennessee at a rate of at least 67.5% of the federal Medicare program's standard rate for participating providers. This directly affects public and private air ambulance companies with a Tennessee base that provide covered emergency or nonemergency transports to TennCare recipients. The bill mandates this reimbursement rate for all covered services, applying to transports occurring on or after the law's effective date. It amends Tennessee Code Sections 71-5-165 (Title 71) and related provisions in Title 68.
SB 1377, the Voluntary Portable Benefit Plan Act, allows businesses to voluntarily contribute to portable benefit plans for independent contractors. These plans, administered by third-party providers chosen by the contractor, cover health, disability, unemployment, life insurance, and retirement benefits. Contributions can be made directly by the business or by withholding a portion of the contractor’s pay, but only with a clear written opt-in agreement and the ability to opt out at any time. The bill amends Tennessee law to ensure these contributions cannot be used to determine a worker’s employment classification as an employee or independent contractor.
SB 1290 permanently removes a temporary expiration date for a law that excludes certain testing equipment from being classified as drug paraphernalia. Specifically, it makes permanent the exclusion of equipment used to test for synthetic opioids (like fentanyl) unless the equipment is used to commit a drug crime. This change directly affects harm reduction organizations, public health workers, and law enforcement using such tools for legitimate testing purposes. The bill amends Tennessee Code Annotated Section 39-17-402 by deleting the prior repeal date of July 1, 2025. The law is now permanent and took effect April 3, 2025.
